Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
584.00    5.00 (0.86%)
Bid:
583.00
Ask:
586.00
Spread: 3.00 (0.515%)
Market Cap: £849.08m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Director/PDMR Shareholding

26 Jun 2025 13:49

RNS Number : 6107O
SAGA PLC
26 June 2025
 

26 June 2025

Saga plc

Director/PDMR Shareholding

Pursuant to the notification obligations under Article 19 of the Market Abuse Regulation, Saga plc (Saga or the Company) hereby notifies the following changes in the interests of directors and persons discharging managerial responsibility (PDMRs) in Ordinary Shares of 15 pence each in the Company (Shares).

Grant of Awards under the Saga 2025 Restricted Share Plan (RSP)

On 25 June 2025, the Company granted awards (in the form of nil-cost options) over Shares under the Saga 2025 RSP as set out in column 3 of the below table.

1. Name

2. Status

3. No of Shares

Mike Hazell

Director/PDMR

350,227

Mark Watkins

Director/PDMR

199,672

 

No consideration was paid for the grant of the RSP Awards which are structured as nil cost options. The number of Shares granted under each RSP award has been determined by reference to the price of a Share on Tuesday 24 June 2025 (175.6 pence per Share). 

The normal vesting date of the RSP Awards will be 25 June 2028, being the third anniversary of the award date. Once vested, the RSP Awards will normally be exercisable until the day before the tenth anniversary of the award date. The RSP Awards are subject to a two-year holding period commencing on vesting.

The RSP Awards will ordinarily vest after three years subject to the grantee's continued service and a discretionary underpin that allows the Company's Remuneration Committee (the Committee) to make adjustments to the level of vesting if the Committee believes due to business performance, individual performance or wider Company considerations that the vesting should be adjusted. This will include consideration of all relevant factors, including any windfall gains.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Mike Hazell

2. Mark Watkins

2

Reason for the notification

a)

Position/status

1. Director, Group Chief Executive Officer

2. Director, Group Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Saga plc

b)

LEI

2138004WWUJN94K2LH95

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 15 pence

GB00BMX64W89

b)

Nature of the transaction

Awards made pursuant to the Saga plc 2025 Restricted Share Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. £nil

2. £nil

1. 350,227

2. 199,672

d)

Aggregated information

- Aggregated volume

- Price

 

 n/a

e)

Date of the transaction

25 June 2025

f)

Place of the transaction

Outside of trading venue

 

Enquiries

Saga plc

3 Pancras Square

London

N1C 4AG

Vicki Haynes

Company Secretary

07803 602 139

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSFRDIRFIE
Date   Source Headline
5th Jun 20241:40 pmRNSHolding(s) in Company
5th Jun 20241:34 pmRNSDirector Declaration
29th May 20244:29 pmRNSDirector/PDMR Shareholding
21st May 20249:00 amRNSNotice of AGM
13th May 202410:08 amRNSRepayment of Bond
7th May 20244:32 pmRNSTotal Voting Rights
30th Apr 20249:15 amRNSIssue of Equity
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results
23rd Aug 20227:00 amRNSDirectorate Change
18th Jul 20225:08 pmRNSDirector/PDMR Shareholding
8th Jul 202210:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.